Truist Financial Corp Viatris Inc Transaction History

Truist Financial Corp

$71.8 Billion
Q3 2025

A detailed history of Truist Financial Corp transactions in Viatris Inc stock. As of the latest transaction made, Truist Financial Corp holds 93,469 shares of VTRS stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,469

Previous 108,668 13.99%

Holding current value

$1 Million

Previous $970,000 4.64%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$8.74 - $10.69 $132,839 - $162,477	-15,199 Reduced 13.99%	93,469 $925,000
Q2 2025 Jul 18, 2025	SELL	$7.26 - $9.12 $4,043 - $5,079	-557 Reduced 0.51%	108,668 $970,000
Q1 2025 Apr 29, 2025	SELL	$8.68 - $12.42 $64,943 - $92,926	-7,482 Reduced 6.41%	109,225 $951,000
Q4 2024 Jan 31, 2025	SELL	$11.32 - $13.37 $139,971 - $165,320	-12,365 Reduced 9.58%	116,707 $1.45 Million
Q3 2024 Nov 13, 2024	SELL	$10.32 - $12.13 $1.41 Million - $1.66 Million	-136,552 Reduced 51.41%	129,072 $1.5 Million

Q2 2024 Aug 20, 2024	SELL	$10.05 - $12.02 $279,430 - $334,204	-27,804 Reduced 9.48%	265,624 $2.82 Million
Q1 2024 May 10, 2024	BUY	$11.27 - $13.53 $547,789 - $657,639	48,606 Added 19.85%	293,428 $3.5 Million
Q4 2023 Feb 02, 2024	BUY	$8.77 - $10.85 $644,182 - $796,965	73,453 Added 42.86%	244,822 $2.65 Million
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $59,131 - $69,984	-6,166 Reduced 3.47%	171,369 $1.69 Million
Q2 2023 Aug 01, 2023	SELL	$9.02 - $10.29 $188,743 - $215,318	-20,925 Reduced 10.54%	177,535 $1.77 Million
Q1 2023 May 05, 2023	SELL	$9.2 - $12.26 $28,124 - $37,478	-3,057 Reduced 1.52%	198,460 $1.91 Million
Q4 2022 Feb 17, 2023	BUY	$8.72 - $11.56 $192,180 - $254,770	22,039 Added 12.28%	201,517 $2.24 Million
Q3 2022 Oct 26, 2022	SELL	$8.48 - $11.13 $783,560 - $1.03 Million	-92,401 Reduced 33.99%	179,478 $1.53 Million
Q2 2022 Jul 22, 2022	SELL	$9.95 - $12.27 $456,525 - $562,972	-45,882 Reduced 14.44%	271,879 $2.85 Million
Q1 2022 Apr 22, 2022	SELL	$9.81 - $15.4 $1.66 Million - $2.6 Million	-169,137 Reduced 34.74%	317,761 $3.46 Million
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $1.63 Million - $1.98 Million	-135,155 Reduced 21.73%	486,898 $6.59 Million
Q3 2021 Nov 05, 2021	SELL	$13.25 - $15.13 $446,220 - $509,533	-33,677 Reduced 5.14%	622,053 $8.43 Million
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $684,764 - $852,655	-52,796 Reduced 7.45%	655,730 $9.37 Million
Q1 2021 May 17, 2021	BUY	$13.59 - $18.54 $1.77 Million - $2.41 Million	130,193 Added 22.51%	708,526 $9.9 Million
Q4 2020 Nov 19, 2021	SELL	$14.3 - $18.74 $1.9 Million - $2.49 Million	-133,061 Reduced 18.7%	578,333 $10.8 Million
Q4 2020 Feb 18, 2021	BUY	$14.3 - $18.74 $10.2 Million - $13.3 Million	711,394 New	711,394 $13.3 Million

Others Institutions Holding VTRS

# of Institutions

1,140

Shares Held

971M

Call Options Held

7.74M

Put Options Held

2.47M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Viatris Inc Transaction History